Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2021 | Insights on genomic techniques in myeloma

Mark Bustoros • 14 Oct 2021
IMW 2021
Multiple Myeloma Rare Diseases Smoldering Myeloma Venetoclax
BELLINI

Mark Bustoros, MD, Weill Cornell Medicine, New York, NY, discusses genomic techniques used in the multiple myeloma field. Targeted panels for myeloma, which include only myeloma-specific mutations, have been implemented in various medical centers. Whole-genome sequencing is mainly used for research purposes and can detect more alterations, therefore, providing more information, but it’s not implemented yet in clinical care. Dr Bustoros highlights that in the future, myeloma classification will be molecularly rather than clinically. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.

More from Mark Bustoros

3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
2:25
Biomarkers of progression and risk stratification in asymptomatic Waldenström's macroglobulinemia
Mark Bustoros • 27 Sep 2023
1:11
Advances that have been made in the molecular characterization of multiple myeloma
Mark Bustoros • 27 Sep 2023
1:50
Molecular characteristics of extramedullary myeloma
Mark Bustoros • 27 Sep 2023

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals